Overview
Jan Oosterhuis practices in Rotterdam, Netherlands. Oosterhuis is rated as an Advanced expert by MediFind in the treatment of Teratoma of the Mediastinum. Their top areas of expertise are Swyer Syndrome, Testicular Yolk Sac Tumor, Testicular Cancer, and Teratoma of the Mediastinum.
Their clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Teratoma of the Mediastinum.
Locations
Rotterdam, ZH, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Swyer SyndromeOosterhuis isDistinguished. Learn about Swyer Syndrome.
- Testicular Yolk Sac TumorOosterhuis isDistinguished. Learn about Testicular Yolk Sac Tumor.
- Advanced
- AnorchiaOosterhuis isAdvanced. Learn about Anorchia.
- IntersexOosterhuis isAdvanced. Learn about Intersex.
- Teratoma of the MediastinumOosterhuis isAdvanced. Learn about Teratoma of the Mediastinum.
- Testicular CancerOosterhuis isAdvanced. Learn about Testicular Cancer.
- Turner SyndromeOosterhuis isAdvanced. Learn about Turner Syndrome.
- Experienced
- ChoriocarcinomaOosterhuis isExperienced. Learn about Choriocarcinoma.
- MosaicismOosterhuis isExperienced. Learn about Mosaicism.
- Ovarian CancerOosterhuis isExperienced. Learn about Ovarian Cancer.
- Partial Androgen Insensitivity Syndrome (PAIS)